Latest news & insights
Boyds Regulatory Team contribute to May issue of Regulatory Rapporteur
In the May issue of the TOPRA journal, Regulatory Rapporteur, members of Boyds award-winning regulatory team made significant contributions to the respected, international peer-reviewed journal.
New senior hire for medical writing team at Boyds with appointment of Naomi Clout
We are delighted to welcome Naomi Clout to the team as Senior Regulatory and Medical Writer, after working with the company on a consultancy basis for a number of years.
Carving out a career as a female pharma leader: interview with Dr Karen Mullen
Boyds’ Chief Medical Officer Dr Karen Mullen was recently interviewed by Pf Media about her career journey as a female pharma leader.
Professor Alan Boyd explains the science behind gene therapy in Open Access Government article
An article authored by President and CEO, Professor Alan Boyd, was recently featured in Open Access Government.
Experts at Boyds talk funding for cell and gene therapy development
Dr Nick Meyers, Vice President of Product Development, and Dr Neil Fish, Vice President of Business Development, recently discussed the availability of funding for cell and gene therapy product development with Cell and Gene Therapy Insights.
Spring Budget: R&D tax relief rate announcement
In the Spring Budget, the Chancellor has announced an enhanced R&D tax relief rate for ‘R&D intensive SMEs.’ Professor Alan Boyd, CEO and president of Boyds, responds to the news.
Further growth for regulatory affairs team at Boyds with appointment of Harriet Edwards
We are pleased to announce the appointment of experienced regulatory professional, Harriet Edwards, in response to a sustained rise in demand for specialist regulatory services
Rare Disease Day: Gene therapy trends and innovation for rare diseases
To mark Rare Disease Day 2023, Professor Alan Boyd, President and CEO of Boyds, spoke to Cell and Gene Therapy Insights to share his views on gene therapy trends and innovation in the rare and ultra-rare disease spaces.